CNBC
Pharma stock soars 150% on injectables deal with Wegovy maker Novo
Friday, September 25, 2026
Nanexa, a Swedish drug-delivery company, announced a licensing agreement with Novo Nordisk. The company's stock price increased more than 150 percent following the announcement. The specific terms of the licensing deal were not disclosed in the available information.
Original reporting: https://www.cnbc.com/2026/09/25/wegovy-novo-nordisk-obesity-drugs.html